All Supplements
    Supplement

    Ceylon Cinnamon (Cinnamomum verum)New

    Supplement
    Metabolic Support
    4/10 Evidence

    A spice-derived extract studied for modest improvements in fasting glucose and HbA1c, mainly in people with type 2 diabetes. Ceylon ("true") cinnamon contains far less coumarin than the cheaper cassia types, which matters for long-term use. Most pooled data come from mixed cinnamon species, so Ceylon-specific effect sizes are less certain.

    Mechanism of Action

    Cinnamaldehyde and polyphenolic procyanidins are proposed to enhance insulin receptor signalling (including GLUT4 translocation), slow gastric emptying and inhibit intestinal alpha-glucosidase, blunting post-meal glucose rises. Antioxidant and anti-inflammatory effects are also proposed. Most mechanisms are from cell and animal work.

    Dosing Protocol

    Recommended

    1g per day of powder (typically 1-2 g)

    Standard starting dose based on research

    Therapeutic Range

    0.5

    Minimum

    to

    3

    Maximum

    g per day of powder (typically 1-2 g)

    With meals, once or divided twice daily; 1-2 g with the largest carbohydrate meal is a common approach

    Cycling Protocol

    No established cycling. Reassess glycaemic markers (fasting glucose, HbA1c) after 8-12 weeks and stop if no benefit

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • Modest reductions in fasting blood glucose and HbA1c in adults with type 2 diabetes (pooled RCTs of mixed cinnamon species)
    • Possible reduction in insulin resistance (HOMA-IR) in capsule trials at doses of 2 g/day or less

    Secondary Benefits

    Possible small improvements in lipid profile (inconsistent across meta-analyses)
    Possible blunting of post-meal glucose rise (small trials)

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • •Chronic liver disease or elevated liver enzymes (especially with cassia cinnamon)
    • •Pregnancy at supplement doses (insufficient data)
    • •Planned surgery within 2 weeks (blood-glucose effects)
    • •Known cinnamon allergy

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    Glucose-lowering drugs (metformin, sulfonylureas, insulin) - additive effect; monitor for hypoglycaemia
    Hepatotoxic drugs/alcohol - coumarin load matters mainly with cassia cinnamon
    Anticoagulants - coumarin content (low in Ceylon) is a theoretical concern
    Berberine, chromium, myo-inositol - additive glucose lowering

    Potential Side Effects

    Some users may experience:

    Mouth irritation or contact dermatitis (cinnamaldehyde)
    GI upset or nausea
    Hypoglycaemia when combined with glucose-lowering drugs
    Liver enzyme elevation, mainly with high-coumarin cassia cinnamon

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Label specifies Cinnamomum verum / zeylanicum, not "cinnamon" or cassia
    • Low-coumarin: independent testing showing coumarin well below cassia levels
    • Third-party tested for heavy metals (lead contamination has been reported in some ground cinnamon)
    • Standardised extract or stated g of powder per capsule

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    4/10

    Emerging/Anecdotal

    Limited clinical data, primarily mechanistic studies or user reports

    Classification:
    Emerging/Moderate for glycaemic markers in type 2 diabetes, weak for healthy adults. A 2025 Nutrition Reviews meta-analysis of 28 RCTs (3,054 adults with T2D) reported improved fasting glucose, postprandial glucose, HbA1c and HOMA-IR, strongest with capsules at 2 g/day or less. A 2025 GRADE-assessed meta-analysis (J Health Popul Nutr) reported fasting glucose SMD -1.28 and HbA1c SMD -0.71. A 2025 Frontiers in Nutrition umbrella review found consistent glucose benefit but called effects on blood pressure, lipids and weight controversial. Limitations: heterogeneous species/doses, small short trials, high between-study heterogeneity, likely publication bias. No meta-analysis restricted to Ceylon was found. Scored Emerging (4). Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation